Design, synthesis and study of small molecules with both AR degradation and AKR1C3 inhibitory activities

被引：0
|
作者：
Xing, Enming [1 ]
Kong, Xiaotian [1 ]
Lou, Wei [2 ]
Shi, Ruihua [1 ]
Cheng, Xiaolin [1 ]
Gao, Allen C. [2 ]
Li, Pui Kai [1 ]
机构：
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5681
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5681
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Design, synthesis, and antineoplastic evaluation of isoform selective inhibitors of AKR1C3
    Verma, Kshitij
    Zhang, Tianzhu
    Penning, Trevor
    Trippier, Paul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [2] AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
    Skarydova, Lucie
    Zivna, Lucie
    Xiong, Guangming
    Maser, Edmund
    Wsol, Vladimir
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) : 138 - 144
  • [3] Novel dual inhibitors of AR/AR variants and AKR1C3: Preclinical activities for advanced prostate cancer therapy.
    Gao, Allen
    Ning, Shu
    Armstrong, Cameron
    Xing, Enming
    Lou, Wei
    Li, Pui-Kai
    Evans, Christopher P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [4] CONCURRENT TARGETING AR/AR VARIANTS AND AKR1C3 FOR ADVANCED PROSTATE CANCER THERAPY
    Armstrong, Cameron
    Ning, Shu
    Lou, Wei
    Evans, Christopher
    Li, Pui-Kai
    Gao, Allen
    JOURNAL OF UROLOGY, 2023, 209 : E489 - E489
  • [5] In Vitro Evaluation of the Reductase Activities of Human AKR1C3 Allelic Variants
    Takano, Shiori
    Fukami, Tatsuki
    Ichida, Hiroyuki
    Suzuki, Kohei
    Nakano, Masataka
    Nakajima, Miki
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (09) : 1188 - 1195
  • [6] In vitro CAPE inhibitory activity towards human AKR1C3 and the molecular basis
    Li, Cuiyun
    Zhao, Yining
    Zheng, Xuehua
    Zhang, Hong
    Zhang, Liping
    Chen, Yunyun
    Li, Qing
    Hu, Xiaopeng
    CHEMICO-BIOLOGICAL INTERACTIONS, 2016, 253 : 60 - 65
  • [7] ERG fusion and AKR1C3 form AR signalling feed-forward loop
    Annette Fenner
    Nature Reviews Urology, 2015, 12 (5) : 239 - 239
  • [8] Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer
    Kafka, Mona
    Mayr, Fabian
    Temml, Veronika
    Moeller, Gabriele
    Adamski, Jerzy
    Hofer, Julia
    Schwaiger, Stefan
    Heidegger, Isabel
    Matuszczak, Barbara
    Schuster, Daniela
    Klocker, Helmut
    Bektic, Jasmin
    Stuppner, Hermann
    Eder, Iris E.
    CANCERS, 2020, 12 (08) : 1 - 18
  • [9] ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer Cells
    Powell, Katelyn
    Semaan, Louie
    Conley-LaComb, M. Katie
    Asangani, Irfan
    Wu, Yi-Mi
    Ginsburg, Kevin B.
    Williams, Julia
    Squire, Jeremy A.
    Maddipati, Krishna R.
    Cher, Michael L.
    Chinni, Sreenivasa R.
    CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2569 - 2579
  • [10] Novel dual inhibitor of AKR1C3 and AR/AR variants supresses androgen signaling and inhibits tumor growth
    Gao, A.
    Cameron, A.
    Ning, S.
    Lou, W.
    Evans, C.
    Li, P.
    Armstrong, C.
    EUROPEAN UROLOGY, 2022, 81 : S626 - S626
12345